Mario has joined Horizon in 2016, originally has a Senior Scientist responsible for the development and optimization of Horizon’s CHO GS platform. He recently has moved to a Field Application Scientist role where he supports Horizon’s customers implementing and adjusting Horizon’s CHO GS platform to their unique product and manufacture requirements. Mario has 10 years’ experience in recombinant protein expression starting his career in 2009 when, during his MSC program, he joined the Protein Expression Facility of the University of Manchester. He then completed his PhD at the University of Manchester in 2016 where he focused his research on the transcriptional biology of recombinant proteins in CHO cells and its relevance for the bioprocessing field. Prior to join Horizon, Mario was a Principal Scientist at Fujifilm Diosynth Biotechnologies, developing recombinant CHO cell lines suitable for the manufacture of biotherapeutics.